250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Biotech Startup Investors in Australia

A list of 50 angel investors and VC funds that invest in Biotech startups based in Australia. We rank investors based on the number of investments they made in Biotech companies from Australia. We update this investor list every month.

Top 50 Biotech Startup Investors in Australia

Investor Biotech Australia investments
Uniseed Ventures 21
Brandon Capital 15
Medical Research Commercialisation Fund (MRCF) 11
Stoic VC 7
OneVentures 6
Artesian VC 5
Melbourne Angels 5
Main Sequence Ventures 5
Horizons Ventures 4
Yuuwa Capital 3
Starfish Ventures 3
Clean Energy Finance Corporation 3
Empath Ventures 2
Sydney Angels 2
Brisbane Angels 2
Grok Ventures 2
BridgeLane Capital 2
Allan Moss 2
Vectr 2
Possible Ventures 2
Folklore Ventures 2
Global Health Investment Fund (GHIF) 2
Lowercarbon Capital 2
Time Ventures 1
Square Peg Capital 1
Mercia Fund Managers 1
Skalata 1
Twynam Agricultural Group 1
Australian Nuclear Science and Technology Organization 1
VU Venture Partners 1
Lilly Ventures 1
Regal Funds Management 1
Daniel Petre 1
Accelerating Commercialisation - AusIndustry 1
Southern Cross Venture Partners 1
Giant Leap Fund 1
BioScience Managers Limited 1
Catherine Lacavera 1
Dexcom Ventures 1
UniSA Ventures 1
Terra Rossa Capital 1
Vaekstfonden 1
QIC BioVentures 1
Tin Alley Ventures 1
Alium Capital 1
Acre Venture Partners 1
HealthCare Ventures 1
Agronomics 1
AbbVie Biotech Ventures 1
Powerhouse Ventures 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Uniseed Ventures VC Fund · Brisbane, Queensland, Australia
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
  • Biotechnology, Manufacturing, Health Care
  • Series A, Seed, Funding Round
  • Australia, United States, United Kingdom
Portfolio highlights
  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture. Our high-level introduction and detailed insights into our innovative solutions, exceptional collaborations, and dedicated team make it easy to understand WHO we are, WHAT we do, and HOW we do it. Stay updated with valuable resources, customer portal, and regular content via our blog. Contact us today to collaborate and optimize your farm's productivity and sustainability.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Morse Micro — Morse Micro Breaks RecordWorld's Longest Wi-Fi HaLow Connection at 3 KilometersWatch Now Smarter, farther, better. Meet the latest Wi-Fi, HaLow, 802.11ah.
Brandon Capital VC Fund · Melbourne, Victoria, Australia · 2 investments in the past 12 months
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Entact Bio — Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.
  • Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
  • Pathios Therapeutics — Pioneering a novel macrophage conditioning approach to delivering breakthrough cancer therapies
Medical Research Commercialisation Fund (MRCF) VC Fund · Melbourne, Victoria, Australia
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Glyscend — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
  • Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
  • Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Stoic VC VC Fund · Sydney, New South Wales, Australia
Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Seed, Funding Round, Series A
  • Australia, United States, United Kingdom
Portfolio highlights
  • Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture. Our high-level introduction and detailed insights into our innovative solutions, exceptional collaborations, and dedicated team make it easy to understand WHO we are, WHAT we do, and HOW we do it. Stay updated with valuable resources, customer portal, and regular content via our blog. Contact us today to collaborate and optimize your farm's productivity and sustainability.
  • Lenexa Medical — Lenexa Medical is driving towards better healthcare solutions for patients in hospital and aged-care by preventing pressure injuries and empowering clinicans.
OneVentures VC Fund · Sydney, New South Wales, Australia · 2 investments in the past 12 months
OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series A, Debt Financing, Funding Round
  • Australia, United States, Israel
Portfolio highlights
  • ImmVirX — ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect.
  • StrongDM — Manage access to any server, database, or Kubernetes instance in minutes. Fully auditable, replayable, secure, and drag-and-drop easy.
  • Employment Hero — Employment Hero is Australia's top cloud-based HR, payroll and benefits platform for employers & employees. FREE trial for...
Artesian VC VC Fund · Melbourne, Victoria, Australia · 7 investments in the past 12 months
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Series A, Pre-Seed
  • Australia, United States, Hong Kong
Portfolio highlights
  • Bygen — Bygen delivers high-quality activated carbon products while also facilitating large-scale, long-term carbon dioxide sequestration.
  • Sitemate — Sitemate builds user friendly software which thousands of industrial companies use every day to streamline their paperwork and processes.
  • Braingaze — Braingaze solves major challenges around cognitive disorders of the brain. We use a patented neuro-biomarker based on small involuntary eye movements. These are triggered by functional games, the resulting signal is analysed using algorithms trained by Deep Learning based on actual real patient / control cases. We adress pre-symptomatic stagesof Alzheimer's disease and the most common child cognitive disorder ADHD. Our tools are on the market and covered by a CE Mark as a medical device. Our pipeline includes detection / diagnostic tools as well as digital therapy solutions that have shown to reduce symtoms by over 50%.
Melbourne Angels VC Fund · Melbourne, Victoria, Australia
Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.
Show more
Investment focus
  • Biotechnology, Information Technology, Manufacturing
  • Angel, Seed, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
  • Apop Imaging — Apop Imaging develops and commercialises novel imaging, diagnostic and therapeutic tools to improve patient outcomes based on our proprietary calcitonin receptor antibody technology.
  • Alkira Software — Deliver interactive content and answer customer queries at scale using conversational AI. TalkVia offers quick and easy NO CODE voice and chat solutions for Amazon Alexa, Google Assistant, Siri and web based chatbots.
Main Sequence Ventures VC Fund · Sydney, New South Wales, Australia · 14 investments in the past 12 months
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Series A, Seed, Series B
  • Australia, Philippines, United States
Portfolio highlights
  • Xefco — Xefco is a company that develops novel textile and coating technologies. It uses a global network of research partners to develop advanced manufacturing solutions and apply cutting-edge materials science, with an emphasis on functional enhancements, sustainable manufacturing, and decreased resource consumption.
  • MGA Thermal — MGA Thermal, specialists in thermal energy storage technology. Renewable, high-power, economical, modular, safe and sustainable thermal storage solutions.
  • Cauldron Ferm — Cauldron is sustainably delivering the precision fermented prototypes of today to the supermarket shelves of tomorrow.
Horizons Ventures VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 17 investments in the past 12 months
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more
Investment focus
  • Biotechnology, Artificial Intelligence, Software
  • Series A, Series B, Seed
  • United States, United Kingdom, Canada
Portfolio highlights
  • Fano Labs — We are one of the leading AI companies specialising on Language AI technologies for enterprises in customer services, compliance and other lines of businesses.
  • Voyage Foods — Voyage Foods has made sustainable and scalable alternatives to foods that have current obstacles –environmental, social, and health alike. Our breakthrough technology provides endless opportunities to make delicious, nearly identical, versions of beloved foods, without compromising individual health or our planet. We replicated the world’s favoritefoods so that we can all enjoy them, forever.
  • Cauldron Ferm — Cauldron is sustainably delivering the precision fermented prototypes of today to the supermarket shelves of tomorrow.
Yuuwa Capital VC Fund · Perth, Western Australia, Australia
Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. They are actively seeking outstanding investment opportunities where Yuuwa can provide both capital and expertise to help founders, management and early investors to turn good ideas into great companies.
Show more
Investment focus
  • Biotechnology, Analytics, Health Care
  • Series A, Seed, Series B
  • Australia
Portfolio highlights
  • Nexgen Plants Pty Limited — Healthy plants, healthy people, living planet. Nexgen develop's plants for future generations that will improve the environment and health of future generations.
  • icetana — icetana Motion Intelligence dramatically improves the active monitoring of security surveillance networks, with AI video anomaly detection and video analytics.
  • Agworld Pty Ltd — Agworld Farm Management software allows you to collect data at all levels and enables you to extract maximum value from this data; optimising profitability. The Agworld ecosystem is utilised by growers, agronomists and service providers on farms across the world.
Starfish Ventures VC Fund · Melbourne, Victoria, Australia
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more
Investment focus
  • Software, Enterprise Software, Information Technology
  • Series A, Series B, Funding Round
  • United States, Australia, Philippines
Portfolio highlights
  • Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
  • DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,209,756 freelance designers compete to create amazing designs for your business. Start Today!
  • Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.
Clean Energy Finance Corporation VC Fund · Sydney, New South Wales, Australia · 6 investments in the past 12 months
The Clean Energy Finance Corporation invests using a commercial approach to overcome market barriers and mobilize investment in renewable energy, energy efficiency, and low emissions technologies. They seek to catalyze and leverage private sector funding for the commercialization and deployment of clean energy technologies necessary for thetransition to a carbon-constrained economy.
Show more
Investment focus
  • Energy, Renewable Energy, Solar
  • Series B, Series A, Seed
  • Australia, United States, France
Portfolio highlights
  • Neoen — Neoen is an independent energy company, develops, finances, builds, and operates power plants based on renewable energies in France, Portugal, Australia, Mexico, Egypt, and El Salvador. It operates solar, wind, and biomass power plants. The company, through its subsidiaries, also specializes in the development of marine renewable energy projects inFrance; supports photovoltaic project developers and investors in the design, construction, operation, and maintenance of solar power plants in France and abroad; and develops solar and wind farms.
  • Relectrify — Unlocking extra lifetime and performance of batteries via advanced battery management (BMS) technology.
  • Renewable Metals — Renewable Metals' unique alkali recycling process recovers critical minerals from old batteries so they can be used again and again.
Empath Ventures VC Fund · Los Angeles, California, United States · 4 investments in the past 12 months
Empath Ventures is a venture capital firm that mainly invests in psychedelic medicine companies. The firm specializes in the fields of investment financial services, finance, and venture capital. It was founded in 2021 and headquartered in Los Angeles California.
Show more
Investment focus
  • Health Care, Biotechnology, Personal Health
  • Seed, Convertible Note, Series A
  • United States, United Kingdom, Canada
Portfolio highlights
  • Psylo — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
  • TARA Mind — TARA Mind enables safe, effective, affordable mental health therapies with a premium network of therapists and ketamine clinics.
  • Motif Neurotech — Motif Neurotech is a company that develops minimally invasive bioelectronic implants for monitoring and treating severe mental illnesses.
Sydney Angels VC Fund · Sydney, New South Wales, Australia
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more
Investment focus
  • Software, SaaS, Apps
  • Seed, Funding Round, Angel
  • Australia, United States
Portfolio highlights
  • Remi AI — A.I-Powered Demand Forecasting, Supply Chain AI, & Price Optimisation | Remi AI
  • Trendspek — Trendspek's 3D software lets you manage high-value built assets faster, safer and with more accuracy. With millimetre detail, interact with exact digital replicas of infrastructure from your desk and collaborate with global stakeholders. Book a call with us to get started.
  • Apollo Secure — Cyber for Humans - an automated cybersecurity platform for startups and small businesses to improve security maturity and simplify security compliance.
Brisbane Angels VC Fund · Brisbane, Queensland, Australia · 3 investments in the past 12 months
Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.
Show more
Investment focus
  • Information Technology, Software, Artificial Intelligence
  • Seed, Angel, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • PropCode — PropCode is a online platform, that helps in researching for town planning queries. the rules can be complex, and make it easy to get the right answers.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Apollo Secure — Cyber for Humans - an automated cybersecurity platform for startups and small businesses to improve security maturity and simplify security compliance.
Grok Ventures VC Fund · Surry Hills, New South Wales, Australia · 4 investments in the past 12 months
Backing a better tomorrow
Show more
Investment focus
  • Renewable Energy, Software, Biotechnology
  • Series A, Series B, Seed
  • Australia, United States, Hong Kong
Portfolio highlights
  • Gridmo — gridmo accelerates the connection of generation to the grid. Unlock access to fast and accurate power system studies.
  • Lydian — Lydian aims to accelerate the decarbonization of the chemical industry by electrifying the chemical production process. Founded in 2021 by Branko Zugic, Lydian is headquartered in
  • Antora Energy — Antora converts low-cost, intermittent renewable electricity into a reliable, on-demand source of zero-emissions industrial heat and power.
BridgeLane Capital VC Fund · Sydney, New South Wales, Australia
The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme
Show more
Investment focus
  • Software, Financial Services, Health Care
  • Seed, Series B, Funding Round
  • Australia, Germany
Portfolio highlights
  • Agerris — Agerris is a field robotics and AI start-up for the agriculture industry, based on technology created at the Australian Centre for Field Robotics, the University of Sydney, where they have been developing air and ground robotic solutions for the agriculture industry since 2005.
  • Sprout Stack
  • Evrima Technologies — Our clinical trial recruitment and management services put participants first. Trusted, timely clinical trial results are a good thing - for everybody.
Allan Moss Angel · Sydney, New South Wales, Australia
Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Funding Round, Series A, Seed
  • Australia, United States, The Netherlands
Portfolio highlights
  • Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
Vectr VC Fund · Sheung Wan, Hong Kong Island, Hong Kong · 2 investments in the past 12 months
Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.
Show more
Investment focus
  • FinTech, Financial Services, Artificial Intelligence
  • Seed, Series A, Pre-Seed
  • United States, Hong Kong, Singapore
Portfolio highlights
  • Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
  • Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
  • MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Possible Ventures VC Fund · Munich, Bayern, Germany · 18 investments in the past 12 months
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more
Investment focus
  • Software, Information Technology, Biotechnology
  • Seed, Pre-Seed, Series A
  • Germany, Australia, United States
Portfolio highlights
  • Insempra — Origin.Bio creates synthetic microorganisms that can make many of the same ingredients as traditional chemical industrialization processes today, but with significantly fewer energy requirements and waste produced while eradicating the need for petrochemicals.The company drives the convergence of engineering with biology, using DNA as theprogramming language. Rather than editing genetic material only in or out of DNA, engineers can hack entirely new organisms that have never existed — all powered by computing, automation, and artificial intelligence (AI)/machine-learning while leveraging millions of years of evolution. Operating at an atomic level, the company farms organisms with microscopic precision and integrates them into existing original equipment manufacturer (OEM) manufacturing processes. This asset-light approach enables Origin.Bio to generate sustainable materials at speed in a cost-effective way, without compromising on performance.
  • Sumday — Non - financial accounting software. Start carbon accounting, properly, with the support of your existing advisors
  • Cosmic Aerospace — Cosmic Aerospace is a pioneering aerospace technology company dedicated to advancing the boundaries of propulsion systems and enabling innovative solutions for space exploration. The company collaborates with leading space agencies, research institutions, and commercial partners to design, test, and implement these groundbreaking technologies.
Folklore Ventures VC Fund · Sydney, New South Wales, Australia
Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.
Show more
Investment focus
  • Software, Apps, Information Technology
  • Seed, Series A, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • Kry10 — Kry10 is a safe operating system for SDMs.It makes the transition to an intelligent, cloud-connected, and adaptively driven future possible for automobiles, electricity grids, satellites, and medical equipment.
  • HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
  • SimConverse — SimConverse is a simulation platform that uses generative AI to play the role of any patient, colleague or casualty.
Global Health Investment Fund (GHIF) VC Fund · New York, New York, United States
The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series B, Series C, Funding Round
  • United States, India, Austria
Portfolio highlights
  • Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
  • CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Lowercarbon Capital VC Fund · New York, New York, United States · 19 investments in the past 12 months
Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.
Show more
Investment focus
  • Biotechnology, Renewable Energy, Energy
  • Seed, Series A, Series B
  • United States, United Kingdom, France
Portfolio highlights
  • Zanskar — Zanskar develops a predictive platform informed by massive data for discovering previously unknown geothermal resources. Its platform includes subsurface characterization technology and massive data sets, enhancing and reducing risk in the exploration of geothermal resources.
  • Mosa Meat — Mosa Meat produces slaughter-free hamburgers. The burger is harvested from cow cells, rather than raising and slaughtering a whole animal. By growing meat naturally from cells, Mosa Meat strives to accelerate the transition to a truly sustainable global food system.
  • Xcimer Energy — Xcimer Energy offers a laser-driven fusion to provide cheap, abundant, and carbon-free energy. It is used to transform the energy marketplace that integrates low-cost excimer laser technology with the HYLIFE reaction chamber concept to design an Inertial Fusion Energy (IFE) system. This system overcomes long-standing obstacles to viable fusionpower.The company was founded in 2021 and is headquartered in Redwood City,, California.
Time Ventures VC Fund · 2 investments in the past 12 months
Time Ventures is an investment fund for Marc Benioff.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Series A, Series B, Seed
  • United States, Canada, Germany
Portfolio highlights
  • Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with ArteraAI. Transforming cancer therapy through innovation.
  • Moonhub — Hire Top Talent On Demand With Expert Recruiters and AI
  • CarbonCapture — CarbonCapture Inc. is a direct air capture company creating technologies to decarbonize the atmosphere. Contact us if you're interested in our mission.
Square Peg Capital VC Fund · Melbourne, Victoria, Australia · 26 investments in the past 12 months
Square Peg is a global investment firm on a mission to empower exceptional founders. With investing teams in Sydney, Melbourne, Tel Aviv, and Singapore, Square Peg invests in emerging technology companies across the internet economy.
Show more
Investment focus
  • Software, Internet, IT
  • Series A, Series B, Seed
  • Australia, United States, Singapore
Portfolio highlights
  • ROKT — Rokt is the global leader in ecommerce technology & software solutions, driving more value per transaction with personalized experiences. Request a demo today.
  • SaasGuru — Get started with a personalised cert prep journey and make your certification goal a reality in two weeks. Salesforce and ServiceNow Certifications
  • Partly — Auto parts distributors, manufacturers, dismantlers, marketplaces and software providers use Partly's software and API to add fitment and manage parts online.
Mercia Fund Managers VC Fund · Henley In Arden, Warwickshire, United Kingdom · 7 investments in the past 12 months
Mercia Asset Management providing equity and debt to regional businesses with growth ambition. We are your capital partners from scale-up to exit.
Show more
Investment focus
  • Software, Health Care, Science/Engineering
  • Seed, Funding Round, Series A
  • United Kingdom, United States, Australia
Portfolio highlights
  • Turbine — Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutictargets or indications, untangling the complexity of cancer.
  • Log my Care — Log My Care is a free electronic care planning and care management system for home care providers. Its platform provides a to-do log, which is shared with care employees to let them know their tasks and gives printable reports about activity performance that enable managers to operate care institutes in a hassle-free way.
  • Role Mapper Technologies — Automate and transform how you design and manage job descriptions across your organisation. Hire, retain and grow an inclusive and diverse workforce with AI powered Intelligent Job Design.
Skalata VC Fund · Melbourne, Victoria, Australia · 10 investments in the past 12 months
Giving Australian founders access to the education, capital and networks needed to build significant, sustainable, global businesses of the future.
Show more
Investment focus
  • Software, Education, Apps
  • Pre-Seed, Seed
  • Australia, United States, United Kingdom
Portfolio highlights
  • humii — Humii provides actionable insights to companies by tracing customer interactions.
  • Nucanon — Narrative design software for game developers
  • SupplyScope — SupplyScope is an all-in-one AI platform that focuses on compliance automation and product workflows for retailers, marketplaces, and brands.
Twynam Agricultural Group VC Fund · Sydney, New South Wales, Australia · 2 investments in the past 12 months
Twynam Group is a leading Australian Funds Manager investing in early-stage climate tech. We also operate an agricultural and property portfolio.
Show more
Investment focus
  • Biotechnology, Agriculture, Seafood
  • Series A, Seed, Pre-Seed
  • United States, Australia, India
Portfolio highlights
  • Voltpost — The lamppost electric vehicle charger.
  • Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
  • Alt Mobility — ALT Mobility is a full-stack EV leasing platform offering mobility as a service (MaaS) for commercial vehicle users.
Australian Nuclear Science and Technology Organization VC Fund · Clayton, Victoria, Australia
Australian Nuclear Science and Technology Organisation is one of Australia's most important research infrastructures. Thousands of scientists in industry and academia gain access to state-of-the-art instruments every year. ANSTO operates much of Australia's landmark infrastructure, including OPAL, one of the world's most advancednuclear reactors; the Australian Synchrotron; the National Imaging Facility Research Cyclotron; and the Centre for Accelerator Science.
Show more
Investment focus
  • Health Care, Biotechnology, Pharmaceutical
  • Funding Round
  • Australia
Portfolio highlights
  • Clarity Pharmaceuticals — Clarity is a clinical stage company developing products to address the growing need for the use of radiopharmaceuticals in oncology.
VU Venture Partners VC Fund · San Francisco, California, United States · 5 investments in the past 12 months
A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech
Show more
Investment focus
  • Software, Health Care, Machine Learning
  • Seed, Funding Round, Series A
  • United States, Colombia, India
Portfolio highlights
  • Hadean — Hadean are a venture backed tech startup providing the most simple and secure platform for cloud native development. Intuitive and developer friendly, the Hadean Platform provides a friction free route to a cloud-native infrastructure. It lets you write applications once and deploy anywhere, taking care of setup, configuration, scaling, securityand more.Hadean have developed two flagship applications. Aether Engine provides distributed load balancing for agent-based simulations, while Muxer is a network model that utilises distributed edge networks. The result is spatial simulations of unparalleled size and complexity, where thousands of concurrent users can join and interact. Hadean have found traction in gaming, healthcare, virtual events and defence with industry leading companies such as Microsoft, Minecraft and CAE.
  • MarketForce — MarketForce connects Africa’s informal retail outlets and consumers directly to suppliers of consumer goods and financial services by digitizing orders, delivery, and payments with the aim of solving the last mile distribution challenge.
  • Dayta AI — SaaS Shopper Analytics - Cyclops presents you insightful data like shopper demographics, bahavioral metrics and many more. Drive more sales and traffic with AI now!
Lilly Ventures VC Fund · Indianapolis, Indiana, United States
Lilly Ventures is the venture capital arm of Eli Lilly and Company responsible for life science investing in North America and Europe. Its primary goal is to facilitate the success of companies in its areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently has $200 million under managementand focuses on three major areas of interest. It partner actively with the management teams of its portfolio companies to realize the potential of their technologies.
Show more
Investment focus
  • Health Care, Biotechnology, Science/Engineering
  • Series C, Series B, Series A
  • United States, Israel, Australia
Portfolio highlights
  • IpiNovyx Bio — Orange Grove Bio partners with leading research universities to advance preclinical biotech programs in the oncology space. The company leverages its venture capital and drug development expertise to help patients and build biotech ecosystems.
  • Evox Therapeutics — Evox Therapeutics is harnessing and engineering the natural delivery capabilities of extracellular vesicles to develop an entirely novel class of biotherapeutics.
  • Kymera Therapeutics — Advancing targeted protein degradation to deliver next-generation medicines
Regal Funds Management VC Fund · Sydney, New South Wales, Australia
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more
Investment focus
  • Software, Financial Services, FinTech
  • Funding Round, Series B, Convertible Note
  • Australia, United States, United Kingdom
Portfolio highlights
  • Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
  • Send Payments — SendFX provides cross-border payment and remittance services to individuals and SMEs.
  • Send Payments — Send is a fast-growing fintech delivering embedded finance solutions to well-known brands.
Daniel Petre Angel · Sydney, New South Wales, Australia
Daniel Petre is the Founder of StartGiving. He was a Founding Chairman and Board Member at Ninemsn. He attended the University of Sydney.
Show more
Investment focus
  • SaaS, Software, Banking
  • Seed, Pre-Seed, Series A
  • Australia
Portfolio highlights
  • Ento — Ento was founded in Australia in 2009 and provides one platform for HR, WFM and engagement. Since then we’ve become the chosen solution for over 3,000 workplaces across retail, hospitality, health, community, and more; rostering more than 30 million shifts for businesses ranging in size from 10 to 2,000+ staff.Our software is part of the nextgeneration of workforce management tools; cloud-based, accessible via a smartphone, tablet or desktop, and integrated with leading ATS, POS and payroll systems to provide a complete solution.
  • Psylo — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
  • Kismet — Find the best disability or healthcare service to support your journey
Accelerating Commercialisation - AusIndustry VC Fund · Canberra, Australian Capital Territory, Australia
A grant program offered by AusIndustry as part of the Australian Government’s National Innovation and Science Agenda
Show more
Investment focus
  • Software, Mining, Hardware
  • Grant, Pre-Seed
  • Australia
Portfolio highlights
  • Neuromersiv — Neuromersiv empowers stroke and brain injury survivors with clinically designed virtual reality-based neurological rehabilitation solutions.
  • Tiny Bright Things — Melbourne-based company Tiny Bright Things was cofounded in 2020 by long-time research collaborators Ray Dagastine and Chris Bolton. We invented Halo microscopy to transform the way researchers and manufacturers look at small or transparent things. This helps manufacturers in areas like agrichemicals and pharmaceuticals (where the size and shape ofpowders are critical) and researchers at every stage of discovery— particularly in nanotechnology (where samples are especially tiny) and life sciences (where samples are often also transparent).
Southern Cross Venture Partners VC Fund · North Sydney, New South Wales, Australia
Southern Cross Venture Partners was launched in 2006 by veteran venture capitalists who have managed and operated companies themselves. Southern Cross Venture Partners assist early stage technology companies that demonstrate the potential for exceptional growth and market leadership build significant businesses. The founding principle of SouthernCross is partnership -- they are passionately committed to doing everything they can to help their portfolio companies succeed. Their team has a strong record of utilizing their start-up and management experience, industry knowledge, network of business/customer relationships, and recruiting skills to assist in building significant shareholder value.Southern Cross is currently investing in companies that fit their investment criteria. They prefer to act as lead or co-lead in the early stages where they have experience that can help build value rapidly. They do not have a minimum investment amount, however, a typical initial investment will be $2 million to $5 million with an ability to invest more money in later rounds.
Show more
Investment focus
  • Software, Manufacturing, Renewable Energy
  • Funding Round, Series B, Series A
  • United States, Australia, Singapore
Portfolio highlights
  • Sunman — Sunman Energy is a technology company founded by a group of industry veterans delivering the future of Solar. Through the research and development of composite materials, Sunman has successfully commercialized the world’s first glass-free, lightweight and flexible Panel – eArc. Replacing glass completely, eArc brings solar power to markets andapplication scenarios that were previously impossible.
  • Wave Computing — The future of high-tech in online casino is a bright one. For example, RFID technology will help casinos track and identify stolen chips. In addition, these systems can also predict player behavior and betting patterns. The latter are especially useful if a player is caught while he is trying to switch out his cards. These ... Read more
  • Brisbane Materials Technology — Since 2005, we have helped thousands of people get the perfect domain name.
Giant Leap Fund VC Fund · Melbourne, Victoria, Australia · 5 investments in the past 12 months
Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.
Show more
Investment focus
  • Health Care, Software, Sustainability
  • Seed, Series A, Funding Round
  • Australia, United States, United Kingdom
Portfolio highlights
  • Fortanix — Fortanix is building a new security category with its Runtime Encryption(R) technology using Intel SGX. Just like encryption today protects data at rest and data during motion, Runtime Encryption(R) keeps keys, data, and applications completely protected even when infrastructure has been compromised and even root users are malicious.Fortanix's Self-Defending Key Management Service (SDKMS) is a next-generation cloud native solution for your enterprise encryption needs. It offers key generation, management, distribution, encryption-as-a-service, HSM, KMIP, and tokenization all rolled-in as a single product the highest possible level of security and cloud scale. Available as both FIPS certified appliance and a globally available SaaS (with Equinix's strong SLA), SDKMS offers incredible simple central management, server-side load balancing, central tamper-proof logging, RESTful APIs, and Runtime Encryption(R) plugin to run custom code.Fortanix's Runtime Encryption(R) Platform allows customers to bring any docker container and run them securely inside Intel SGX without any modification. It allows customers to share data with each other without losing control of the data, run analytics on sensitive data, run applications securely in remote cloud, move PII-heavy sensitive data to public cloud, etc. Fortanix's Enclave Development Platform (EDP) allows customers to write Rust code to run natively as SGX enclaves. Supported by mainline Rust compiler, developers find EDP as the easiest and the most secure way of developing new applications.In the short time, Fortanix has developed strategic partnership with Equinix and IBM cloud and counts multiple F50 companies as its customers. Fortanix is a Gartner Cool Vendor and also was runner up in RSA Innovation Sandbox among 500+ security companies where judges called it "holy grail of security". Fortanix has more than ten patents pending for its innovation.
  • Mindset Health — Mindset Health is a digital therapeutics company that helps people manage chronic health issues like irritable bowel syndrome and anxiety with app-based hypnotherapy.
  • More Good Days — More Good Days offers evidence-based pain management programes, education, and health services.
BioScience Managers Limited VC Fund · Melbourne, Victoria, Australia
BioScience Managers Pty Ltd (formerly IB Managers) is a leading life sciences investment firm, headquartered in Melbourne, Australia. Established in 2003, BioScience Managers offers a global, multi-disciplinary team, bringing an international perspective together with the track record, networks and expertise required to convert that perspectiveinto informed, high return investment decisions.We operate a high value-add model, providing assistance and support to portfolio companies via our global team and international network of independent industry advisors. With combined experience of over 170 investments, more than 40 IPO’s/ reversals in Europe, the USA and Australia, and a diverse skillset specific to the bio-based industries, we aim to provide investee companies with significant value-add over and above capital invested.Alongside our funds management business, Phillip Bioscience Advisory provides specialist corporate advisory services to healthcare and life sciences companies.
Show more
Investment focus
  • Health Care, Pet, Medical
  • Funding Round
  • Canada, Australia
Portfolio highlights
  • Nexvet — Our mission is to be a revolutionary force in the growing US$25 billion global animal pharmaceutical market. Only Nexvet can produce therapeutic antibodies that are 100% customised to target new species – like cats and dogs.Monoclonal antibody therapies have represented a new generation of highly effective, safe and targeted medicines inhumans. We think it’s time companion animals reaped the benefits of human medical progress in this field.Nexvet’s unique technology, PETisation™, ensures 100% customisation of a therapy to a new species, reducing the chances of immune challenges, and ensuring a more ‘natural’ fit between the therapy and the patient. Many chronic conditions in pets remain poorly treated by current veterinary therapies, such as pain and various inflammatory diseases– which has guided Nexvet’s focus towards these indications.To ensure we succeed in transforming animal medicine, we’ve brought together a team with an extraordinary global track record in animal and human health. We are working with leading contractors, advisors, drug development partners, academic groups, veterinarians and animal interest groups around the world to develop our pipeline to the highest standards.Senior executives and researchers from the world’s largest animal health brands are counted among our Board, management, and advisors, and together we’re building connections worldwide to make our vision a reality.
  • Canary Medical — Canary is giving medical devices a voice and letting medical data be heard.
Catherine Lacavera Angel
Catherine Lacavera is the VP, Legal at Google.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Seed, Pre-Seed
  • Canada, Australia
Portfolio highlights
  • Skritswap — skritswap software reduces the reading level of information.
  • HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
Dexcom Ventures VC Fund · San Diego, California, United States
The inaugural fund will seek to identify and invest in opportunities to supplement growth in the core business and advance the development of adjacent technologies for the future.
Show more
Investment focus
  • Sensor, Medical, Wearables
  • Funding Round
  • Australia
Portfolio highlights
  • Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.
UniSA Ventures VC Fund
UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed
  • Australia
Portfolio highlights
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Framework — All-in-one productivity tool for teams & individuals.
Terra Rossa Capital VC Fund · Adelaide, South Australia, Australia
Terra Rossa Capital Pty Ltd operates as a venture capital fund. The Company invests in life science companies. Terra Rossa Capital serves clients in Australia.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B
  • Australia
Portfolio highlights
  • Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable point‐of‐care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Vaekstfonden VC Fund · Hellerup, Hovedstaden, Denmark · 22 investments in the past 12 months
Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.
Show more
Investment focus
  • Software, Science/Engineering, IT
  • Seed, Funding Round, Pre-Seed
  • Denmark, United States, United Kingdom
Portfolio highlights
  • Orbex Space — Founded in 2015, Orbex is Europe’s leading private launch services company, focused entirely on supporting the needs of the small satellite industry.Orbex has developed one of the most advanced, low carbon, high performance micro-launch vehicles in the world. They launch customer satellites into polar and sun-synchronous low Earth orbits from aunique, modern launch location in the heart of the European continent.They offer a flexible core launch service and a wide suite of supporting services that make life easier for customers. Their European location means shorter supply lines, easier communications and reduced operational costs. Their advanced launch vehicle means higher reliability, more flexible mission profiles and a regular, scheduled launch service.
  • Go Autonomous — B2B commerce, simplified. Fastest way for companies to digitize manual quotes and orders. An order-to-cash automation SaaS platform powered by AI
  • Breye Therapeutics — Protecting the Gift of Sight
QIC BioVentures VC Fund · Brisbane, Queensland, Australia
QIC BioVentures, previously known as Queensland BioCapital Funds, was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. Like any other QIC Fund, QBF's purpose is to maximize investment returns for QIC's clients. QBF does not provide grants or other formsof assistance.
Show more
Investment focus
  • Health Care, Biotechnology, Science/Engineering
  • Series A
  • Australia
Portfolio highlights
  • Protagonist Therapeutics — Protagonist Therapeutics is a biotechnology company dedicated to the discovery of novel peptide and small molecule compounds that mimic or inhibit therapeutically-relevant protein-protein interactions.
Tin Alley Ventures VC Fund · Carlton, Victoria, Australia
Tin Alley Ventures collaborates with companies and researchers in the University of Melbourne's ecosystem to invest in & support world-changing businesses.
Show more
Investment focus
  • Medical, Health Care, Therapeutics
  • Pre-Seed
  • Australia
Portfolio highlights
  • Psychae Therapeutics — Psychae Therapeutics is a biotechnology company creating transformative psychedelic-assisted therapies that combine the best of nature with modern pharmaceutical science. Our vision is to integrate the profound healing properties of botanical psychedelic substances with rigorous evidence-based medi
Alium Capital VC Fund · Sydney, New South Wales, Australia
Alium Capital are Investment Fund Managers offering an Innovative Investment Fund Focused on Generating Returns & Effectively Managing Risk
Show more
Investment focus
  • Software, Financial, Science/Engineering
  • Series A, Series B, Seed
  • Australia, United States, Singapore
Portfolio highlights
  • Alex — Alex is 100% digital, built from the ground up by an energetic team of bankers, focused on customer's needs, not ours. Further information regarding Alex’s restricted Banking Authority is available at www.alex.bank/legal
  • Beforepay — Beforepay understands that traditional pay cycles are a form of financial stress. So we set out to find a better way, giving Australians the control and confidence that comes with managing your own money, on your terms.That’s why we created Pay On Demand™ - a service that allows you to access the money you have earned at work, when you choose todo so. After all, it is yours!The app also automatically predicts when your bills are due, shows you how much is OK for you to spend, and automatically creates budgets for you, effortlessly.
  • DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,091,001 freelance designers compete to create amazing designs for your business. Start Today!
Acre Venture Partners VC Fund · Santa Monica, California, United States · 3 investments in the past 12 months
Driven by a mission to redefine food, Acre invests in companies creating systemic change in the food system to address the growing problems of human and environmental health. Acre makes venture-stage investments in highly disruptive platform business across the food value chain, with a particular focus on the agriculture, food tech and consumerverticals. Taken together, these investments have the ability to form the foundation of an integrated new approach to food system evolution.
Show more
Investment focus
  • Food/Beverage, Gaming, Science/Engineering
  • Series A, Series B, Series C
  • United States, Brazil, Argentina
Portfolio highlights
  • Planet FWD — Planet FWD is the leading carbon assessment platform for consumer brands.
  • Loam Bio — Loam Bio is developing tech that allows for crops to be inoculated with symbiotic micro-organisms.
  • People Science — People Science offers data collection technology and services for clinical research studies of alternative medicines and wellness interventions.
HealthCare Ventures VC Fund · Cambridge, Massachusetts, United States
HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series B, Series A, Series C
  • United States, Australia, United Kingdom
Portfolio highlights
  • Colorescience — Know Better Skin with Colorescience. From mineral sunscreen to clinical skincare products, achieve a clear, even complexion and protect your skin from the damaging effects of the sun and environmental aggressors such as pollution. Shop Now!
  • Leap Therapeutics — Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, is engaged in acquiring and developing novel therapeutics. The company focus is to identify translational-stage molecules in the areas of cell signaling and immuno-oncology.
  • Proteostasis Therapeutics — Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, aredesigned to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.
Agronomics VC Fund · Douglas, South Lanarkshire, United Kingdom · 5 investments in the past 12 months
Venture capital investment can raise funds for your small business. Venture Capital Firms in the UK like Agronomics is a biotech venture capital firm which invest into the clean meat sector.
Show more
Investment focus
  • Biotechnology, Food and Beverage, Food Processing
  • Seed, Series A, Series B
  • United States, Finland, Australia
Portfolio highlights
  • Onego Bio — Onego Bio is a cell ag company, specialized in animal-free egg white protein. We produce bioalbumen with an innovative precision fermentation process.
  • Liberation Labs — Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.
  • Clean Food Group — Clean Food Group provides sustainable ‘CLEAN’ alternatives to these fats and oils, ranging from liquid oils like soybean to hard fats like palm oil, cocoa butter, and milk fat. Clean Food Group produces sustainable food ingredients that are better for our environment and health without compromising on teste or performance.
AbbVie Biotech Ventures VC Fund · North Chicago, Illinois, United States
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Togetherwith its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.
Show more
Investment focus
  • Biotechnology, Science/Engineering, Health Care
  • Series A, Series B, Series C
  • United States, China, Italy
Portfolio highlights
  • Nitrase Therapeutics — Nitrase Therapeutics is a platform company developing drugs against a newly identified class of enzymes called Nitrases, initially targeting Parkinson’s disease. The therapies that Nitrome is developing will target these enzymes and potentially help slow or halt the progression of diseases such as Parkinson’s. While the initial focus is onParkinson's disease, the company aims to expand its proprietary platform to include other disease indications.
  • Quanta Therapeutics — Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes. The company was founded in 2018 and is based in San Francisco, CA.
  • AmbAgon Therapeutics — AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein. AmbAgon Therapeutics was founded by Christian Ottmann, Lucas Brunsveld, and Michelle Arkin.
Powerhouse Ventures VC Fund · Oakland, California, United States · 4 investments in the past 12 months
Powerhouse Ventures backs entrepreneurs building the digital infrastructure for rapid decarbonization.
Show more
Investment focus
  • Software, Energy, Solar
  • Seed, Series A, Pre-Seed
  • United States, Australia, United Kingdom
Portfolio highlights
  • SHAED — SHAED offers a mobility platform. It focuses on Shared, Hydrogen, Autonomous, Electric, and Distribution technologies. It speeds up the shift from traditional engines to electric and sustainable vehicles in the commercial sector.
  • Rock Rabbit — We make the rebate process quick, accurate, and efficient so contractors and homeowners can focus on their projects.
  • ThinkLabs AI — ThinkLabs AI is a specialist AI development and deployment firm. Its mission is to empower critical industries and infrastructure with trustworthy AI towards global energy sustainability.
Investors by industry
Investors by country
Investors in Australia by industry